Efficacy and Safety of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D X CD3 Bispecific Antibody, in Patients with Relapsed/refractory Multiple Myeloma (RRMM): Updated Results from MonumenTAL-1.
HemaSphere（2022）
Key words
International Myeloma Working Group
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined